STIM

Neuronetics Inc

2.15

Nov 06 • 3:59 PM ET -0.28 (-11.52%)

2.15

Aftermarket • 7:49 PM ET +0.00 (0.01%)

Healthcare Medical Devices USA Micro NASD

Nov 05, 2:35 AMNeuronetics posts profitable Q3 operating results, beats revenue estimates with $42M and maintains 2026 revenue guidance of $160–$164M as capital sales mix rises

Peers: BWAY ECOR MOBI NPCE LIVN CLPT NXL CMPS LFST ACHC

| Held by: VTI PSIL VXF IWC BUSM QQQS

Scroll to Statements

Index	-
Market Cap	167.12M
Enterprise Value	230.43M
Income	-23.08M
Sales	159.76M
Book/sh	0.24
Cash/sh	0.36
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	658
IPO	Jun 28, 2018

P/E	-
Forward P/E	-
PEG	-
P/S	1.05
P/B	8.93
P/C	5.95
P/FCF	-
EV/EBITDA	-
EV/Sales	1.44
Quick Ratio	1.82
Current Ratio	2.01
Debt/Eq	4.69
LT Debt/Eq	4.42
Option/Short	Yes / Yes

EPS (ttm)	-0.33
EPS next Y	-0.24
EPS next Q	-0.07
EPS this Y	50.54%
EPS next Y	17.59%
EPS next 5Y	30.48%
EPS past 3/5Y	24.64% 16.51%
Sales past 3/5Y	31.76% 24.81%
EPS Y/Y TTM	60.22%
Sales Y/Y TTM	23.01%
EPS Q/Q	83.63%
Sales Q/Q	12.51%
Earnings	Nov 04 BMO
EPS/Sales Surpr.	72.34% 2.97%

Insider Own	62.10%
Insider Trans	1.35%
Inst Own	29.85%
Inst Trans	-9.76%
ROA	-16.64%
ROE	-100.20%
ROIC	-22.76%
Gross Margin	49.47%
Oper. Margin	-9.39%
Profit Margin	-14.45%
SMA20	0.34%
SMA50	-12.51%
SMA200	14.27%
Trades

Shs Outstand	77.73M
Shs Float	29.46M
Short Float	24.48%
Short Ratio	4.31
Short Interest	7.21M
52W High	3.44 -37.50%
52W Low	0.80 168.75%
Volatility	15.62% 8.65%
ATR (14)	0.24
RSI (14)	46.61
Beta	1.29
Rel Volume	2.19
Avg Volume	1.67M
Volume	3,664,207

Perf Week	-4.44%
Perf Month	0.47%
Perf Quarter	-0.92%
Perf Half Y	29.91%
Perf YTD	55.80%
Perf Year	-14.68%
Perf 3Y	66.02%
Perf 5Y	-60.04%
Perf 10Y	-
Recom	1.00
Target Price	6.00
Prev Close	2.43
Price	2.15
Change %	-11.52%

Consensus

Strong Buy

Avg. Price Target

$6.00

Implied Upside

+179.1%

Analysts4incl. previous ratings

Rating Distribution3 Buy · 1 Hold · 0 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Sep 11, 2026	Initiated	RB. Riley Securities	Buy	$5	+132.6%
Jul 20, 2026	Initiated	BBTIG Research	Buy	$5	+132.6%
Aug 13, 2024	Downgrade	WWilliam Blair	Outperform → Mkt Perform
Oct 13, 2021	Downgrade	WWilliam Blair	Outperform → Mkt Perform
Oct 13, 2021	Downgrade	BBTIG Research	Buy → Neutral
Jan 22, 2021	Upgrade	WWilliam Blair	Mkt Perform → Outperform
Feb 06, 2020	Initiated	BBTIG Research	Buy	$11	+411.6%
Jul 24, 2018	Initiated	CCanaccord Genuity	Buy

Nov-04-26 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +19.69% -10.17%
02:17PM	Neuronetics Posts First GAAP Operating Profit And Raises Margin Outlook, But A Held Revenue Guide And Thin Cash Keep The Turnaround On Probation (Earnings Whispers)
10:34AM	Neuronetics Reports 12.5% Revenue Growth to $42 Million in Q3 2026 as Losses Narrow (InvestorsHub)
08:04AM	Neuronetics: Q3 Earnings Snapshot (Associated Press)
07:50AM	Neuronetics Reports Third Quarter 2026 Financial and Operating Results (GlobeNewswire)
02:57PM	Loading…
Oct-27-26 02:57PM	Neuronetics Must Prove Its Profit Pivot Holds As Neurostar Revenue Turns Choppier (Earnings Whispers)
Oct-21-26 08:30AM	Neuronetics to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call (GlobeNewswire)
Sep-08-26 08:32AM	NeuroStar Advances Practice Innovation with First-Ever TMS Integration with an EHR/EMR System (GlobeNewswire)
Aug-11-26 05:02PM	Neuronetics Inc (STIM) (Q2 2026) Earnings Call Highlights: Revenue Growth and Margin Expansion ... (GuruFocus.com) +47.00%
11:01AM	Neuronetics Narrows Q2 Loss as Greenbrook Growth Drives 9% Revenue Increase (InvestorsHub)
07:57AM	Neuronetics: Q2 Earnings Snapshot (Associated Press)
07:50AM	Neuronetics Reports Second Quarter 2026 Financial and Operating Results (GlobeNewswire)
Aug-03-26 08:00AM	Neuronetics and Jorey Chernett Announce Shared Vision (GlobeNewswire) +9.09%
Jul-31-26 05:00PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jul-28-26 08:32AM	Greenbrook Opens National Center of Excellence for Advanced Interventional Psychiatry in Rockville, Maryland (GlobeNewswire)
08:30AM	Loading…
08:30AM	Neuronetics to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call (GlobeNewswire)
Jul-20-26 04:05PM	Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes (GlobeNewswire) +24.69% -6.93%
Jul-06-26 08:30AM	Neuronetics to Participate in a Panel Discussion at B. Riley Securities' Mind, Muscle & Vision Summit on July 16, 2026 (GlobeNewswire) +10.64%
Jun-02-26 04:30PM	Neuronetics Appoints Robert Greene as Senior Vice President Sales (GlobeNewswire) -6.59% -10.90%
08:32AM	Neuronetics Highlights Continued Advancements in TMS Research at CTMSS 2026 (GlobeNewswire)
May-14-26 08:32AM	Neuronetics and ANT Neuro Announce Strategic Collaboration to Integrate Neuronavigation with NeuroStar TMS Treatment (GlobeNewswire) -13.91%
May-05-26 07:57AM	Neuronetics: Q1 Earnings Snapshot (Associated Press) +7.43%
07:50AM	Neuronetics Reports First Quarter 2026 Financial and Operating Results (GlobeNewswire)
Apr-29-26 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +14.12%
Apr-21-26 08:30AM	Neuronetics to Report First Quarter 2026 Financial and Operating Results and Host Conference Call (GlobeNewswire) -5.06%
Apr-13-26 08:32AM	Optum/United Healthcare/United Behavioral Health Expands NeuroStar TMS Coverage to Include Psychiatric Mental Health Nurse Practitioners (GlobeNewswire)
Apr-07-26 07:00AM	Neuronetics Comments on Letter from Pointillist Family Office (GlobeNewswire) -10.23%
Apr-06-26 04:30PM	Neuronetics Announces Chief Financial Officer Transition (GlobeNewswire) +15.79%
04:05PM	Largest Independent Shareholder of Neuronetics, Inc., Jorey Chernett, Calls for Immediate and Comprehensive Review of Strategic Alternatives, Including Sale of TMS Business (PR Newswire)
Mar-17-26 08:17AM	Neuronetics: Q4 Earnings Snapshot (Associated Press Finance) -9.93%
07:50AM	Loading…
07:50AM	Neuronetics Reports Fourth Quarter and Full Year 2025 Financial and Operating Results (GlobeNewswire)
07:45AM	Neuronetics Appoints Dan Reuvers as President and Chief Executive Officer (GlobeNewswire)
Mar-03-26 08:30AM	Neuronetics to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call (GlobeNewswire)
Feb-11-26 12:20AM	Neuronetics (STIM) Stock Rises 41% After Hours: What's Going On? (Benzinga) +23.29%
Feb-10-26 04:34PM	Neuronetics Announces Selected Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
Nov-20-25 08:30AM	Neuronetics to Participate at the Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire) -12.75%
Nov-12-25 10:33AM	TRICARE West Expands NeuroStar TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression (GlobeNewswire)
Nov-04-25 04:08PM	Neuronetics Inc (STIM) Q3 2025 Earnings Call Highlights: Revenue Surges Amid Strategic Acquisitions (GuruFocus.com)
08:40AM	Neuronetics (STIM) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
07:39AM	Neuronetics: Q3 Earnings Snapshot (Associated Press Finance)
07:05AM	Neuronetics Reports Third Quarter 2025 Financial and Operating Results and Announces CEO Transition Plan (GlobeNewswire)
Nov-03-25 08:09AM	Neuronetics Inc (STIM) Q3 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Oct-31-25 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Oct-30-25 08:32AM	Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence (GlobeNewswire) -6.90%
Oct-21-25 08:30AM	Neuronetics to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call (GlobeNewswire) +5.49%
Sep-17-25 08:32AM	New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar Advanced Therapy, to Treat Major Depressive Disorder (MDD) (GlobeNewswire)
Sep-02-25 03:49AM	Neuronetics, Inc. (STIM) Positions as Neurohealth Leader with Adolescent Breakthrough (Insider Monkey) -5.71%
Aug-06-25 04:45PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -6.60% -5.65%
Aug-05-25 08:20AM	Neuronetics (STIM) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
07:19AM	Neuronetics: Q2 Earnings Snapshot (Associated Press Finance)
07:05AM	Neuronetics Reports Second Quarter 2025 Financial and Operating Results (GlobeNewswire)
Aug-04-25 04:30PM	Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference (GlobeNewswire) +5.43%
10:04AM	What To Expect From Neuronetics Inc (STIM) Q2 2025 Earnings (GuruFocus.com)
Jul-30-25 08:32AM	NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents (GlobeNewswire)
Jul-22-25 08:30AM	Neuronetics to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call (GlobeNewswire) +8.76%
Jul-15-25 07:30AM	Neuronetics Appoints New Chief Financial Officer (GlobeNewswire)
Jul-09-25 07:20AM	Neuronetics Showcases NeuroStar TMS Data at Clinical TMS Meeting (Insider Monkey)
Jun-19-25 07:00PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jun-10-25 08:31AM	Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook's Personalized Care Trial Program (GlobeNewswire)
Jun-02-25 04:30PM	Neuronetics Set to Join Russell 2000 and Russell 3000 Indexes (GlobeNewswire)
May-14-25 08:31AM	Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month (GlobeNewswire)
May-07-25 03:09AM	Neuronetics Inc (STIM) Q1 2025 Earnings Call Highlights: Revenue Surge Amidst Margin Challenges (GuruFocus.com)
May-06-25 08:20AM	Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:20AM	Neuronetics: Q1 Earnings Snapshot (Associated Press Finance)
07:10AM	Neuronetics Reports First Quarter 2025 Financial and Operating Results (GlobeNewswire)
May-05-25 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
07:40AM	Integra LifeSciences (IART) Q1 Earnings Miss Estimates (Zacks)
Apr-30-25 05:50AM	Why Neuronetics, Inc. (STIM) is Surging in 2025 (Insider Monkey)
Apr-22-25 08:30AM	Neuronetics to Report First Quarter 2025 Financial and Operating Results and Host Conference Call (GlobeNewswire)
Apr-02-25 03:26PM	BrainsWay: Strong Growth Prospects Matter Little To The Market (Seeking Alpha)
Mar-31-25 08:31AM	Evernorth Health Services, a Cigna Company, Expands NeuroStar TMS Coverage for Adolescents Struggling with Depression (GlobeNewswire)
Mar-29-25 11:45PM	Neuronetics: Explosive Growth Poised To Soar On FDA Breakthroughs (Seeking Alpha)
Mar-27-25 04:30PM	Neuronetics Reports Updated Fourth Quarter and Full Year 2024 Financial and Operating Results (GlobeNewswire) -5.75%
Mar-18-25 09:55AM	Wall Street Analysts Think Neuronetics (STIM) Could Surge 34.98%: Read This Before Placing a Bet (Zacks)
Mar-05-25 02:06AM	Neuronetics Inc (STIM) Q4 2024 Earnings Call Highlights: Revenue Growth Amidst Rising Expenses ... (GuruFocus.com) +7.11%
Mar-04-25 11:29PM	Q4 2024 Neuronetics Inc Earnings Call (Thomson Reuters StreetEvents) +18.78%
07:36AM	Neuronetics: Q4 Earnings Snapshot (Associated Press Finance)
07:10AM	Neuronetics Reports Fourth Quarter and Full Year 2024 Financial and Operating Results (GlobeNewswire)
Mar-03-25 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
07:20AM	Neuronetics Inc (STIM) Q4 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
Feb-22-25 05:08PM	Neuronetics, Inc. (STIM): Among the Hot Penny Stocks to Buy Now (Insider Monkey)
Feb-21-25 08:30AM	Neuronetics to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call (GlobeNewswire) -13.96%
Feb-07-25 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -13.76% +25.73%
07:54AM	Neuronetics Announces Pricing of $18 Million Underwritten Public Offering of Common Stock (GlobeNewswire)
Feb-06-25 04:23PM	Neuronetics Announces Launch of Underwritten Public Offering of Common Stock (GlobeNewswire) +8.87%
Feb-03-25 07:27PM	Why Neuronetics Inc (STIM) Is Skyrocketing So Far In 2025 (Insider Monkey) +7.81%
Jan-29-25 08:31AM	NeuroStar Unveils Two Significant Publications on TMS Therapy for Depression (GlobeNewswire) +6.31%
Jan-13-25 08:00AM	Neuronetics Provides Business Update and Issues 2025 Guidance (GlobeNewswire) +36.84%
Dec-18-24 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +5.38% -5.84%
Dec-16-24 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +19.27%
Dec-10-24 10:00AM	Neuronetics and Greenbrook TMS Announce Closing of Transaction (GlobeNewswire)
Nov-20-24 08:30AM	Neuronetics to Present at the Piper Sandler 36th Annual Healthcare Conference (GlobeNewswire) +6.26%
Nov-13-24 02:10AM	Neuronetics Inc (STIM) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Rising Expenses ... (GuruFocus.com) -11.65%
Nov-12-24 06:45PM	CORRECTION Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results (GlobeNewswire) -37.27%
04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
08:20AM	Neuronetics (STIM) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
07:19AM	Neuronetics: Q3 Earnings Snapshot (Associated Press Finance)
07:10AM	Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results (GlobeNewswire)
Nov-11-24 07:26AM	Neuronetics Inc (STIM) Q3 2024 Earnings Report Preview: What to Expect (GuruFocus.com) -5.98%
Oct-29-24 04:30PM	Neuronetics to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call (GlobeNewswire) +5.94%

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Chernett Jorey	10% Owner	Oct 30 '26	Buy	2.27	18,000	40,860	10,620,988	Nov 02 08:49 AM
MACAN WILLIAM ANDREW	Former Officer	Aug 19 '26	Proposed Sale	3.10	149,891	463,934		Aug 19 02:13 PM
MACAN WILLIAM ANDREW	Officer	Aug 18 '26	Proposed Sale	3.21	121,033	388,274		Aug 18 04:46 PM
Chernett Jorey	10% Owner	Aug 14 '26	Buy	3.16	14,000	44,240	10,602,988	Aug 17 10:13 AM
Chernett Jorey	10% Owner	Jul 14 '26	Buy	1.78	35,000	62,300	10,588,988	Jul 15 09:33 AM
Sullivan Keith J	Former Officer and Director	Jun 08 '26	Proposed Sale	1.29	42,164	54,345		Jun 08 04:38 PM
Chernett Jorey	10% Owner	May 19 '26	Buy	1.17	100,000	117,000	10,553,988	May 20 12:39 PM
Chernett Jorey	10% Owner	May 12 '26	Buy	1.34	475,000	636,500	10,453,988	May 13 08:31 AM
Chernett Jorey	10% Owner	Apr 20 '26	Buy	1.58	100,000	158,000	9,878,988	Apr 22 09:39 AM
Chernett Jorey	10% Owner	Apr 21 '26	Buy	1.51	100,000	151,000	9,978,988	Apr 22 09:39 AM
Chernett Jorey	10% Owner	Mar 30 '26	Buy	1.25	385,442	481,802	9,778,988	Mar 30 07:41 PM
Chernett Jorey	10% Owner	Mar 27 '26	Buy	1.35	500,000	675,000	9,393,276	Mar 30 09:37 AM
Chernett Jorey	10% Owner	Mar 25 '26	Buy	1.40	125,000	175,000	8,868,276	Mar 27 09:33 AM
Chernett Jorey	10% Owner	Mar 26 '26	Buy	1.44	25,000	36,000	8,893,276	Mar 27 09:33 AM
Pfanstiel Steven	EVP, CFO and Treasurer	Mar 19 '26	Sale	1.34	16,431	22,018	828,781	Mar 24 05:52 PM
Sullivan Keith J	Former Officer & Director	Mar 19 '26	Sale	1.34	46,289	62,027	1,590,924	Mar 24 05:50 PM
MACAN WILLIAM ANDREW	EVP, CLO and CS	Mar 19 '26	Sale	1.34	16,005	21,447	897,270	Mar 24 05:48 PM
Chernett Jorey	10% Owner	Mar 20 '26	Buy	1.41	169,472	238,956	8,743,276	Mar 23 09:34 AM
Chernett Jorey	10% Owner	Mar 18 '26	Buy	1.35	607,400	819,990	8,123,804	Mar 20 08:51 AM
Chernett Jorey	10% Owner	Mar 19 '26	Buy	1.33	450,000	598,500	8,573,804	Mar 20 08:51 AM
MACAN WILLIAM ANDREW	Officer	Mar 19 '26	Proposed Sale	1.32	16,005	21,123		Mar 19 04:36 PM
Sullivan Keith J	Officer	Mar 19 '26	Proposed Sale	1.32	46,289	61,092		Mar 19 04:25 PM
Chernett Jorey	10% Owner	Mar 17 '26	Buy	1.16	531,000	615,960	7,516,404	Mar 18 10:36 AM
MACAN WILLIAM ANDREW	EVP, CLO and CS	Mar 04 '26	Sale	1.34	609	816	879,525	Mar 06 04:29 PM
MACAN WILLIAM ANDREW	Officer	Mar 04 '26	Proposed Sale	1.34	609	814		Mar 04 03:09 PM
MACAN WILLIAM ANDREW	EVP, CLO and CS	Feb 26 '26	Sale	1.35	3,427	4,626	880,134	Feb 27 04:34 PM
Sullivan Keith J	President and CEO	Feb 26 '26	Sale	1.35	8,452	11,410	1,524,713	Feb 27 04:33 PM
Sullivan Keith J	Officer	Feb 26 '26	Proposed Sale	1.34	8,452	11,366		Feb 26 03:33 PM
MACAN WILLIAM ANDREW	Officer	Feb 26 '26	Proposed Sale	1.34	3,427	4,609		Feb 26 03:16 PM
Sullivan Keith J	President and CEO	Feb 12 '26	Sale	1.65	33,847	55,848	1,533,165	Feb 18 05:44 PM
MACAN WILLIAM ANDREW	EVP, CLO and CS	Feb 12 '26	Sale	1.65	14,120	23,298	673,561	Feb 18 05:42 PM
MACAN WILLIAM ANDREW	EVP, CLO and CS	Feb 10 '26	Sale	1.55	3,485	5,402	687,681	Feb 12 04:32 PM
Sullivan Keith J	President and CEO	Feb 10 '26	Sale	1.55	40,976	63,513	1,567,012	Feb 12 04:31 PM
Sullivan Keith J	Officer	Feb 12 '26	Proposed Sale	1.65	33,847	55,712		Feb 12 03:19 PM
MACAN WILLIAM ANDREW	Officer	Feb 12 '26	Proposed Sale	1.65	14,120	23,242		Feb 12 03:12 PM
MACAN WILLIAM ANDREW	Officer	Feb 10 '26	Proposed Sale	1.55	3,485	5,392		Feb 10 04:28 PM
Sullivan Keith J	Officer	Feb 10 '26	Proposed Sale	1.55	40,976	63,398		Feb 10 04:14 PM

Neuronetics, Inc. is a commercial stage medical technology company, which focuses on designing, developing and marketing products that improve the quality of life for patients who suffer from neurohealth disorders. It operates through United States and International geographical segments. The company was founded by Steven B. Waite, Bruce J. Shook, Norman R. Weldon, and Thomas D. Weldon in 2003 and is headquartered in Malvern, PA.

CEOMr. Daniel L. Reuvers

CPAMr. Nir Naor C.F.A.

Senior Vice President of SalesMr. Robert Greene

Executive Vice President & General Manager of GreenbrookMr. Cory S. Anderson

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

STIM

Neuronetics Inc

Upgrade your Finviz experience